Biogen pays $900M to settle doctor kickback allegations
Headline from NWI Times
Biogen has agreed to pay $900 million to resolve allegations that it violated federal law by paying kickbacks to doctors in the form of speakers and consulting fees to persuade
NWI Times's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
Biogen has agreed to pay $900 million to resolve allegations that it violated federal law by paying kickbacks to doctors in the form of speakers and consulting fees to persuade
Biogen is accused of causing submissions of false claims to Medicare and Medicaid by paying physicians kickbacks to prescribe its multiple sclerosis drugs Avonex, Tysabri and Tecfidera.
Pharmaceutical company Biogen Inc. has agreed to pay $900 million to settle allegations that it paid kickbacks to doctors to recommend its multiple sclerosis drugs, causing false submission claims to Medicare and Medicaid.
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
Biogen pays $900M to settle doctor kickback allegations | Since Then
